Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Bivalirudin

Brand: 
NICE TA: 230
Indication: MI with persistent ST-segment elevation (NICE TA230)
Disease category: Cardiovascular system
Commissioning responsibility: CCG
PbR excluded: No

Background

In tarrif
LMMG is adopting the local decision made prior to April 2013

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA230 - Bivalirudin for the treatment of ST-segment-elevation myocardial infarction  

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red